DE69510782T2 - DNA, WELCHE FÜR DEN VORLÄUFER DES INTERLEUKIN-1 BETA KONVERTIERENDEN ENZYMS KODIERT (ICE rel-II) - Google Patents

DNA, WELCHE FÜR DEN VORLÄUFER DES INTERLEUKIN-1 BETA KONVERTIERENDEN ENZYMS KODIERT (ICE rel-II)

Info

Publication number
DE69510782T2
DE69510782T2 DE69510782T DE69510782T DE69510782T2 DE 69510782 T2 DE69510782 T2 DE 69510782T2 DE 69510782 T DE69510782 T DE 69510782T DE 69510782 T DE69510782 T DE 69510782T DE 69510782 T2 DE69510782 T2 DE 69510782T2
Authority
DE
Germany
Prior art keywords
icerel
cdna
recombinant
precurrent
interleukin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69510782T
Other languages
English (en)
Other versions
DE69510782D1 (de
Inventor
Donald W Nicholson
Ambereen Ali
Neil A Munday
John P Vaillancourt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Canada Inc
Original Assignee
Merck Frosst Canada and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Frosst Canada and Co filed Critical Merck Frosst Canada and Co
Publication of DE69510782D1 publication Critical patent/DE69510782D1/de
Application granted granted Critical
Publication of DE69510782T2 publication Critical patent/DE69510782T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6472—Cysteine endopeptidases (3.4.22)
    • C12N9/6475—Interleukin 1-beta convertase-like enzymes (3.4.22.10; 3.4.22.36; 3.4.22.63)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Obesity (AREA)
  • Communicable Diseases (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69510782T 1994-04-08 1995-04-04 DNA, WELCHE FÜR DEN VORLÄUFER DES INTERLEUKIN-1 BETA KONVERTIERENDEN ENZYMS KODIERT (ICE rel-II) Expired - Lifetime DE69510782T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/225,487 US6110701A (en) 1994-04-08 1994-04-08 DNA encoding precursor of interleukin-1β converting enzyme--related cysteine proteinase II (ICErel -II)
PCT/CA1995/000188 WO1995027793A1 (en) 1994-04-08 1995-04-04 DNA ENCODING PRECURSOR OF INTERLEUKIN-1β CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE II (ICErel-II)

Publications (2)

Publication Number Publication Date
DE69510782D1 DE69510782D1 (de) 1999-08-19
DE69510782T2 true DE69510782T2 (de) 1999-12-30

Family

ID=22845077

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69510782T Expired - Lifetime DE69510782T2 (de) 1994-04-08 1995-04-04 DNA, WELCHE FÜR DEN VORLÄUFER DES INTERLEUKIN-1 BETA KONVERTIERENDEN ENZYMS KODIERT (ICE rel-II)

Country Status (10)

Country Link
US (2) US6110701A (de)
EP (1) EP0754234B1 (de)
JP (1) JP3750136B2 (de)
AT (1) ATE182176T1 (de)
CA (1) CA2187161C (de)
DE (1) DE69510782T2 (de)
DK (1) DK0754234T3 (de)
ES (1) ES2136285T3 (de)
GR (1) GR3031468T3 (de)
WO (1) WO1995027793A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0770141A4 (de) * 1994-06-23 1998-03-04 Human Genome Sciences Inc Interleukin-1-beta-konvertierendes-enzyme-ähnliche apoptosisprotease-1 und 2
FR2723378B1 (fr) * 1994-08-02 1996-10-31 Roussel Uclaf Sequence d'adn codant pour une proteine humaine tx apparentee a l'enzyme de conversion de l'interleukine-1beta, proteine tx, procede de production, compositions pharmaceutiques et leurs applications
WO1996026280A1 (en) * 1995-02-21 1996-08-29 Basf Aktiengesellschaft NOVEL CYSTEINE PROTEASE RELATED TO INTERLEUKIN-1β CONVERTING ENZYME
US6121018A (en) * 1997-03-27 2000-09-19 Smithkline Beecham Corporation Interleukin-1β converting enzyme like apoptosis protease-10
CZ20024085A3 (cs) 2000-06-15 2003-05-14 Smithkline Beecham Corporation Způsob přípravy fyziologicky aktivního IL-18 polypeptidu
CN115772220B (zh) * 2022-11-22 2023-08-11 武汉爱博泰克生物科技有限公司 针对人白介素-1β的兔单克隆抗体及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5416013A (en) * 1990-04-04 1995-05-16 Sterling Winthrop Inc. Interleukin 1β protease and interleukin 1β protease inhibitors
WO1993025685A1 (en) * 1992-06-12 1993-12-23 Massachusetts Institute Of Technology Cloning and characterization of the cell death genes ced-3 and ced-4
JPH08500482A (ja) * 1992-06-12 1996-01-23 マサチューセッツ インスティテュート オブ テクノロジー Ｃｅｄ−３及び関連蛋白質のインヒビター

Also Published As

Publication number Publication date
ATE182176T1 (de) 1999-07-15
CA2187161C (en) 2008-02-05
GR3031468T3 (en) 2000-01-31
US6110701A (en) 2000-08-29
ES2136285T3 (es) 1999-11-16
JP3750136B2 (ja) 2006-03-01
EP0754234A1 (de) 1997-01-22
DE69510782D1 (de) 1999-08-19
WO1995027793A1 (en) 1995-10-19
US6103513A (en) 2000-08-15
JPH09511646A (ja) 1997-11-25
EP0754234B1 (de) 1999-07-14
DK0754234T3 (da) 1999-11-29
CA2187161A1 (en) 1995-10-19

Similar Documents

Publication Publication Date Title
DE69738653D1 (de) Klonierung und charakterisierung von napsin, einer aspartat-protease
PT101297A (pt) Factores mitogenicos gliais, sua preparacao e utilizacao
WO1997036916B1 (en) dUTPASE, ITS ISOFORMS, AND DIAGNOSTIC AND OTHER USES
NZ323795A (en) Isolated nucleic acid molecules encoding AUR-1 (aurora-1) and AUR-2 polypeptides
DE59915205D1 (de) Strukturprotein von AAV, seine Herstellung und Verwendung
ES2059361T3 (es) Complejo de proteinas recombinantes que tiene actividad de factor viii:c su produccion y uso.
ATE415480T1 (de) B7l-1 moleküle
ATE484587T1 (de) Ldcam genannte moleküle
PT83255B (pt) Polipeptidos e anticorpos, caracteristicos do polilomavirus e suas aplicacoes no diagnostico "in vitro" na pervencao e ou na luta contra as infeccoes por papilomavirus
DE69510791T2 (de) DNA, WELCHE FÜR DEN VORLÄUFER DER INTERLEUKIN-1-BETA ÜBERFÜHRENDEN ENZYM-VERWANDTEN PROTEINASE III (ICE rel-III) KODIERT
WO1990003435A3 (fr) Acide nucleique codant pour l'enzyme de conversion de l'angiotensine (eca) humaine, et ses applications, notamment pour le diagnostic in vitro de l'hypertension arterielle
DE69510782D1 (de) DNA, WELCHE FÜR DEN VORLÄUFER DES INTERLEUKIN-1 BETA KONVERTIERENDEN ENZYMS KODIERT (ICE rel-II)
ATE224443T1 (de) Mch2, eine apoptotische cystein-protease, zusammensetzungen für ihre präparation und methoden für ihre verwendung
Henry et al. Co‐operation between metastatic tumor cells and macrophages in the degradation of basement membrane (type IV) collagen
Jima et al. Collagenase activity in human saliva
Tanabe et al. Degradation of enamelins by proteinases found in porcine secretory enamel in vitro
Tanzer et al. Inhibitory effects of tunacamycin on procollagen biosynthesis and secretion
Patrick et al. An acetylcholine receptor preparation lacking the 42,000 dalton component
WO2004060867A3 (en) Secreted protein factor and cell membrane-bound splice variant
HUP0103208A2 (hu) Proteáz kódoló szekvenciákat vagy inhibítoraikat tartalmazó DNS konstrukciók
CA2246430A1 (en) Protein tyrosine phosphatases of hematopoietic cells
Simpson et al. Synthesis of a collagenase inhibitor by gingival fibroblasts in culture
ATE266094T1 (de) Produktion des proteins ingap mit hoher expressionsrate
DE69831242D1 (de) Erhöhte herstellung von sekretierten proteinen durch rekombinante hefezellen
Lannfelt et al. Porphobilinogen deaminase in human erythrocytes: purification of two forms with apparent molecular weights of 40 kDa and 42 kDa

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: MERCK FROSST CANADA LTD., KIRKLAND, QUEBEC, CA